Interdependencies with other services Sample Clauses

Interdependencies with other services. The Provider acknowledges that the Service is provided as part of the wider Substance Misuse Recovery System, delivered by the Trust, ADS and other partners. Therefore, the Provider will ensure they co-operate with the whole of the System and work as part of the System in delivering the Service. As mentioned in clause SDB3.4 (Acceptance and exclusion criteria) the Provider may also be required to liaise and work with Project 3.

Interdependencies with other services. The specialist OG cancer multidisciplinary team is the leader in the NHS for patient care in this area. They provide a direct source of advice and support when other clinicians refer patients into the specialist services. The specialist OG cancer multidisciplinary team also provides education within the NHS to raise and maintain awareness of upper gastro-intestinal cancer and their management. The specialist OG cancer multidisciplinary team will form a relationship with local health and social care providers to help optimise any care for OG cancer provided locally for the patient. This may include liaison with consultants, GPs, community nurses or social workers etc. Co-located services – Intensive/critical care services may be required for some patients undergoing complex surgery and providers will be required to refer to the service specification for critical care. Cancer Networks There are currently (at July 2012) 28 cancer networks across England. Each cancer network will have a Network Site Specific Group (NSSG) covering upper gastrointestinal cancer. This group is made up of clinicians across the network who specialise in upper gastrointestinal cancer. It is the primary source of clinical opinion on issues relating to upper gastrointestinal cancer within the cancer network and is an advisor to commissioners locally. The specialist OG team should ensure they fully participate in the cancer network systems for planning and review of services. The NSSG is responsible for developing referral guidelines, care pathways, standards of care and to share good practice and innovation. They should also collectively implement NICE Improving Outcomes Guidance including the use of new technologies and procedures as appropriate and carry out network and national audits. Each cancer network should agree an up-to-date list of appropriate clinical trials and other well designed studies for oesophago-gatric cancer patients and record numbers of patients entered into these trials/studies by each multidisciplinary team. 3. Applicable Service Standards 3.1 Applicable national standards e.g. NICE, Royal College Care delivered by the specialist OG multidisciplinary team must be of a nature and quality to meet the CQC care standards and the IOG for OG cancers. It is the Trust’s responsibility to notify the commissioner on an exceptional basis should there be any breaches of the care standards. Where there are breaches any consequences will be deemed as being the Trust’s respo...

Interdependencies with other services. Provision of a streamlined SPVU pathway requires effective joint working relationships between the GJNH and QEUH. Both hospitals are interdependent for matters relating to patient flow, clinical governance and efficiency. GJNH will have facilities and imaging infrastructure to support cardiopulmonary diagnostic investigations.‌ QEUH requires access to an acute care infrastructure including coronary care unit and / or high dependency unit for patients who require emergency care if their condition becomes unstable.‌ Due to the requirement of highly expensive medicines for this patient cohort both pharmacy leadership and direct clinical input is paramount for SPVU‌‌

Interdependencies with other services. 3.1 In order to deliver integrated patient-centred, efficient, effective and seamless care, the Provider will need to deliver the Services alongside a range of health partners and related services. 3.2 Providers shall promote the take-up of flu vaccinations by at risk groups were possible and offer immunisation to staff in order to reduce the spread and protect patients. The promotion of materials during flu season and distribution of national leaflets to individuals at risk is required.

Interdependencies with other services. The purpose of the service is to provide comprehensive, fully integrated, high quality clinical and laboratory services. To achieve this, there is a need for close functional interaction between all the sections within the service, the local trust, with the other NHS centres and the centres around the country and also a need for good communication between genetic services and other relevant clinical specialties, such as cardiologists, ventilation teams, gastroenterologists, orthopaedic surgeons, physiotherapists, ophthalmologists, social care advisors, etc. Interdependencies within each centre are detailed below: As part of the local neuromuscular team, the LGMD service has a strong integrated role with the local care of neuromuscular patients, with support from the Northern genetic service, the neuropathology team of the Newcastle Upon Tyne Hospitals NHS Trust and the wider NHS Regular meetings are held with professional from the different subgroups of the service (clinical, laboratory) and from other specialties to ensure a high quality and multidisciplinary service. For example, monthly biopsy meetings and diagnostic meetings are held to discuss difficult or complex clinical cases, with support also from the local neuropathology and neurologists from the Newcastle Upon Tyne Hospitals NHS Trust. In particular, patients could be also admitted to muscle biopsy or muscle MRI investigations at the Newcastle Upon Tyne Hospitals NHS Trust concurrently with the clinical appointment. Joint clinics are also held with other centres, such as for patients with congenital myasthenic syndromes, as one of the consultants working with the Newcastle muscle team, is a world leading expert in this rare condition. Moreover, the centre has working relationship with the other NHS England services for rare neuromuscular disorders as several conditions go in differential diagnosis with congenital muscular dystrophies (as for patients with mutation in the FKRP gene) or congenital myopathies. In this case, the DNA sample of the patient is forwarded to the appropriate service and if the clinical diagnosis is suggestive for one of these conditions, the patient is referred to the service for a clinical opinion. The NHS England service for LGMDs also receives DNA samples and biopsies for patients with clinical conditions allelic to one of those for which we offer service, such as in case of rare congenital forms of MFM or congenital muscular dystrophies caused by mutations in the LMN...

Interdependencies with other services. The Service is commissioned to work closely with other service providers and treatment agencies.

Interdependencies with other services.  The Service will be delivered as part of the 0-19 prevention and early intervention services and support and therefore integrated with relevant services.  The Service will work with services across the County ensuring good partnership working to offer the best support for service users.  The Service will work in partnership with other professionals, including for example but not restricted to Midwifery Services, Schools, Youth Services, Police, VCS, GPs, dental services and other Health and Social Care Practitioners (see Fig 2).  The Service will establish good working relationships with key local partners, including representation on strategic and operational partnership groups and developing services in line with localities and county wide priorities.  The Service will deliver a three locality based model structure and working together to deliver locality based model service for children and their families, with a focus on promotion, prevention and early intervention.  The Service will ensure for children aged 0-6 that a named Public Health Nurse or appropriately trained staff member is linked to each appropriate setting to ensure: o Liaison, information sharing and joint working with GP practices where necessary; o Direct partnership with schools to provide improved access and delivery of NCMP o Promotion of support that children and their families are entitled to, and, as part of that process, encouraging children and young people to access the service o The promotion of an integrated approach to improving child and family health locally  The Service should link to wider stakeholder and services (e.g. hospital and community based health services, VCS) delivering in conjunction with the key practitioners.

Interdependencies with other services. The following interdependencies have been identified: Health Education England (NHS HEE) and the Centre for Pharmacy Postgraduate Education (CPPE) – for governance of the self-declaration of competence process for pharmacists wishing to offer treatment for chlamydia and for the provision of online training modules and training events. Bury Council and the Greater Manchester Shared Services for the production and authorisation of Patient Group Direction. Ruclear (Manchester Foundation Trust) – for the provision of Ruclear chlamydia and gonorrhoea home screening kits. ▇▇▇.▇▇▇▇▇▇▇.▇▇.▇▇ Ruclear (Manchester Foundation Trust) – for the referral of clients for treatment for chlamydia.

Interdependencies with other services. Whole System Relationships All networks have a clinical governance framework in place. This framework enables the network to monitor the quality of care provided to clinicians and families, enable continuous service improvement, encourage clinical excellence and innovation and ensure clear accountability whilst maintaining high levels of safety. Audit and clinical governance NHS England commissioners and the provider will conduct a formal Joint Service Review at each centre at least annually and would expect to meet with the national clinical teams annually. Minimum standards for post-mortem and post-mortem reports as agreed by the Royal College of Obstetricians and Gynaecologists and the Royal College of Pathologists in June 2001. The designated provider should attend mortality meetings in local and referring hospitals if requested to promote good clinical care. Attendance at referring hospitals may, currently, be an aspiration but a target if local demand exists and resource permits. Clinical meetings with fetal medicine specialists, obstetricians, neonatologists clinical geneticists and, where appropriate, other relevant professional groups should occur locally and where possible in referring hospital if resource exists Interdependencies Perinatal Pathology is recognised as a subspecialty of Histopathology by the Royal College of Pathologists. There are close dependencies with obstetric, fetal and maternal medicine, paediatric and medical genetic services. 3. Applicable Service Standards 3. 1 Applicable national standards e.g. NICE, Royal College Relevant published national guidance includes:- • Royal College of Pathologists, Guidelines for Post Mortem Reports, London, 2000 • Royal College of Pathologists, Guidelines on Autopsy Practice, London, 2002 • Royal College of Obstetricians and Gynecologists and Royal College of Pathologists, Fetal and Perinatal Pathology Report of a Joint Working Party, London 2001 • Royal College of Obstetricians and Gynecologists, Late Intrauterine Fetal Death and Stillbirth (Green Top 55), London 2010 • Royal College of Pathologists and The Royal College of Paediatrics and Child Health, Sudden Unexpected Death in Infancy: a multiagency protocol for care and investigation, London, 2004 • Royal College of Pathologists, Code of Practice for Histopathologists and Histopathology Services, London, 2005 • Department of Health, Families and Post Mortems: A code of practice, 2003 • Department of Health, Care and Respect in Death: go...